ArticleInvestigational new drugs2015

Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia.

Franck Morschhauser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.